UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1609-1619

2015

Link zum Volltext

Verfügbarkeit prüfen

Buccal Epithelium, Cigarette Smoking, and Lung Cancer: Review of the Literature

Oncology, 2017-01, Vol.93 (6), p.347-353

2017

Link zum Volltext

Verfügbarkeit prüfen

Isolated Enteric Myeloid Sarcoma as a Rare Etiology of Small Bowel Obstruction in a Young Female Patient

Gastroenterology research, 2022-02, Vol.15 (1), p.39-46

2022

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Journal of clinical oncology, 2004-03, Vol.22 (5), p.785-794

2004

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e448-e458

2019

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e459-e469

2019

Link zum Volltext

Verfügbarkeit prüfen

RXÂ 3117: Activity of an oral antimetabolite nucleoside in subjects with pancreatic cancerâ€“Preliminary results of stage II of the phase Ia/IIb study

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.396-396

2018

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4754-4759

2009

Link zum Volltext

Verfügbarkeit prüfen

Case 7-2000: A 23-Year-Old Man with Hemolytic Anemia and Bloody Diarrhea

The New England journal of medicine, 2000-03, Vol.342 (10), p.722-728

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer

Investigational new drugs, 2009-02, Vol.27 (1), p.75-81

2009

Link zum Volltext

Verfügbarkeit prüfen

Multiple control elements are required for expression of the human CD34 gene

Gene, 1998-11, Vol.222 (2), p.305-318

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia

Investigational new drugs, 2008-04, Vol.26 (2), p.139-149

2008

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight‐based dose using a front‐loading schedule in patients with anemia who have nonmyeloid malignancies

Cancer, 2004-02, Vol.100 (4), p.859-868

2004

Link zum Volltext

Verfügbarkeit prüfen

Hematologic Improvement Following Treatment with TLK199 (Telintra™), a Novel Glutathione Analog Inhibitor of GST P1-1, in Myelodysplastic Syndrome (MDS): Interim Results of a Dose-Ranging Phase 2a Study

Blood, 2004-11, Vol.104 (11), p.1428-1428

2004

Link zum Volltext

Verfügbarkeit prüfen

Isolated Enteric Myeloid Sarcoma as a Rare Etiology of Small Bowel Obstruction in a Young Female Patient

Gastroenterology research, 2022, Vol.15 (1), p.39-46

2022

Link zum Volltext

Verfügbarkeit prüfen

A 23-year-old man with hemolytic anemia and bloody diarrhea

The New England journal of medicine, 2000-03, Vol.342 (10), p.722-728

2000

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to: “Multiple control elements are required for expression of the human CD34 gene” : [Gene 222 (1998) 305–318]

Gene, 1999-10, Vol.239 (1), p.203-203

1999

Link zum Volltext

Verfügbarkeit prüfen

Case records of the Massachusetts General Hospital: Case 7-2000

The New England journal of medicine, 2000-03, Vol.342 (10), p.722

2000

Link zum Volltext

Verfügbarkeit prüfen

Isolation of Immortal Cell Lines from the First Stage of Murine Leukemia Virus-Induced Leukemia

Proceedings of the National Academy of Sciences - PNAS, 1984-09, Vol.81 (17), p.5464-5467

1984

Link zum Volltext

Verfügbarkeit prüfen

Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis

Blood, 2013-11, Vol.122 (21), p.2907-2907

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer

Clinical cancer research, 1995-01, Vol.1 (1), p.57-61

1995

Link zum Volltext

Verfügbarkeit prüfen

Transforming Growth Factor α-Pseudomonas Exotoxin Fusion Protein Prolongs Survival of Nude Mice Bearing Tumor Xenografts

Proceedings of the National Academy of Sciences - PNAS, 1990-06, Vol.87 (12), p.4697-4701

1990

Link zum Volltext

Verfügbarkeit prüfen

Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo

Journal of Industrial Microbiology, 1991-04, Vol.7 (3), p.203-207

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(22)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Female
(9)
Humans
(9)
Oncology
(8)
Aged
(7)
Biological And Medical Sciences
(7)
Male
(6)
Medical Sciences
(6)
Middle Aged
(6)
Adult
(5)
Dose-Response Relationship, Drug
(5)
Tumors
(5)
Animals
(4)
Antineoplastic Agents - Adverse Effects
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Cell Line
(4)
Mice
(4)
Neoplasm Staging
(4)
Treatment Outcome
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

Buccal Epithelium, Cigarette Smoking, and Lung Cancer: Review of the Literature

Isolated Enteric Myeloid Sarcoma as a Rare Etiology of Small Bowel Obstruction in a Young Female Patient

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

RXÂ 3117: Activity of an oral antimetabolite nucleoside in subjects with pancreatic cancerâ€“Preliminary results of stage II of the phase Ia/IIb study

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Case 7-2000: A 23-Year-Old Man with Hemolytic Anemia and Bloody Diarrhea

A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer

Multiple control elements are required for expression of the human CD34 gene

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight‐based dose using a front‐loading schedule in patients with anemia who have nonmyeloid malignancies

Hematologic Improvement Following Treatment with TLK199 (Telintra™), a Novel Glutathione Analog Inhibitor of GST P1-1, in Myelodysplastic Syndrome (MDS): Interim Results of a Dose-Ranging Phase 2a Study

Isolated Enteric Myeloid Sarcoma as a Rare Etiology of Small Bowel Obstruction in a Young Female Patient

A 23-year-old man with hemolytic anemia and bloody diarrhea

Corrigendum to: “Multiple control elements are required for expression of the human CD34 gene” : [Gene 222 (1998) 305–318]

Case records of the Massachusetts General Hospital: Case 7-2000

Isolation of Immortal Cell Lines from the First Stage of Murine Leukemia Virus-Induced Leukemia

Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer

Transforming Growth Factor α-Pseudomonas Exotoxin Fusion Protein Prolongs Survival of Nude Mice Bearing Tumor Xenografts

Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo

Suchergebnisse filtern